Christopher Nolan has revealed a 'lost chapter' of Interstellar, and you can read it right now, Interstellar is almost three hours long, but Christopher Nolan still didn't have enough time to fit in every detail of the film's sprawling story. Fortunately, Wired has teamed up with Nolan to fill in at least one of Interstellar's "lost chapters": the back story of Dr. Mann, who plays a pivotal role in the film's denouement.
The seven-page comic, titled "Absolute Zero," expands on Dr. Mann's experiences after launching into space, and details the motivations behind his actions in the film. "You're not supposed to feel this," thinks Dr. Mann, in the extreme isolation of the ice planet. "The years between are meant to slip by bearably, but they don't."
Iraq's agriculture minister, Falah Hassan al-Zeidan, said that the Islamic State has taken more than one million metric tons of grain from the country and given it to militant-run cities in Syria.
In a statement on Iraq's Agriculture Ministry's website, al-Zeidan said that the wheat and barley were taken from the Nineveh Province in northern Iraq to the cities of Raqqa and Deir al-Zor in Syria.
The news comes months after a similar claim in August, when ISIS allegedly took more than 40,000 metric tons of wheat from the Nineveh and Anbar provinces. Reuters suggests that by taking the grain, ISIS "is hoping to make its self-proclaimed caliphate self-sufficient.
New research published in the Journal of the Federation of American Societies for Experimental Biology (FASEB) suggests that blood tests could be used to detect Alzheimer's disease a full 10 years before it is clinically diagnosed.
The study authors found that the blood test could measure the brain's insulin resistance, which is a symptom of Alzheimer's. Early detection could delay the disease and slow patients' mental decline, Time reports.
The researchers froze blood samples from Alzheimer's patients up to 10 years before they were diagnosed. The levels of IRS-1, an insulin receptor, in the patients' blood indicated which patients had Alzheimer's disease.
The findings are still preliminary — the study used a limited sample size, and the blood test isn't available for public use. The study will "need to be replicated in a larger sample and expanded upon," study author Ed Goetzl told Time. But the researchers are hopeful that the study holds promise for detecting Alzheimer's disease and treating patients.
